Cleveland Clinic Atrial Fibrillation Study | NHLBI Trans-Omics for Precision Medicine Skip to main content

Cleveland Clinic Atrial Fibrillation Study

Cleveland Clinic Lone Atrial Fibrillation GeneBank Study (CCAF) has enrolled patients with lone atrial fibrillation, defined as atrial fibrillation in the absence of significant structural heart disease. Participants were at least 18 years of age with a history of recurring or persistent lone atrial fibrillation, ≤50% coronary artery stenosis in the coronary arteries (if cardiac catheterization done) or with normal stress test results (documentation of normal cardiac catheterization or stress test required if age ≥50 years), and had normal left ventricular ejection fraction (LVEF) 50%. Individuals were excluded if they had heart failure, history of significant valvular disease (>2+ valvular regurgitation, any valvular stenosis), significant coronary artery disease (>50% coronary artery stenosis), prior myocardial infarction, prior percutaneous coronary intervention, or coronary artery bypass graft, or latest LVEF <50%.
Short Name
CCAF
Institution(s)
Cleveland Clinic
Type of Omics
WGS
Approx. Sample Size 365
Disease/Phenotype
early-onset atrial fibrillation
Starting Phase
Phase 1
TOPMed Accession #
phs001189
Omics Center(s) Phase 1
Broad Institute Genomics Platform
Omics Center Contact
Phases Involved
1
PI
Co-PI
Contact
Data Set contact(s)
Project
AFGen
Back to top